NASDAQ · Medical - Healthcare Information Services

HTFL (HTFL) Stock

$50.43 +0.08% NASDAQ: HTFL Healthcare

Valuation

MetricValue
Price$50.43
Market Cap$4.35B
P/E Ratio-35.49
P/B Ratio15.56
P/S Ratio20.49
EPS (TTM)$-3.17
52-Week High$51.19
52-Week Low$20.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-42.25%
ROA-34.36%
ROCE-24.23%
Gross Margin76.80%
Operating Margin-36.13%
Net Margin-55.82%
Debt/Equity0.10
Current Ratio5.20

Annual Financials (USD)

Metric202320242025
Revenue$87.0M$126.0M$176.0M
Operating Profit$-73.0M$-61.0M$-64.0M
Net Profit$-96.0M$-96.0M$-117.0M
EPS$-1.94$-1.53$-1.37
Op Margin-83.6%-48.7%-36.4%

Balance Sheet (USD)

Metric202320242025
Total Assets$185.0M$119.0M$359.0M
Total Liabilities$963.0M$978.0M$59.0M
Cash$123.0M$51.0M$45.0M
Borrowings$161.0M$160.0M$22.0M

Latest News

What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? Motley Fool · Jul 15, 2026 New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management GlobeNewswire · Jul 9, 2026 Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? Motley Fool · Jul 8, 2026 Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? Motley Fool · Jul 4, 2026 Heartflow Insider Sold Shares Worth $1,361,500, According to a Recent SEC Filing MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-76.0M$-69.0M$-54.0M
Investing Cash Flow$-12.0M$-9.0M$-244.0M
Financing Cash Flow$0$2.0M$-1.0M
Net Cash Flow$86.0M$-71.0M$-7.0M
Free Cash Flow$-83.0M$-73.0M$-59.0M

Valuation & Return Ratios

MetricValue
PEG Ratio4.91
EV / EBITDA-40.08
FCF Yield-1.36%
Quick Ratio5.08
Interest Coverage-21.02
Return 1Y48.66%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATEC $9.21 -1.71% -8.57 $1.42B 0.00%
IRON $78.67 +0.03% -11.92 $3.02B 0.00%
LEGNLegend Biotech Corporation $23.58 +0.17% -17.34 $4.36B 0.00%
LIVN $80.16 +0.44% 23.13 $4.40B 0.00%
PRGO $14.43 -1.43% -1.06 $2.00B 10.86%

About HTFL

HTFL stock trades at $50.43 with a market capitalization of $4.35B. The stock is valued at a price-to-earnings (P/E) ratio of -35.49, price-to-book of 15.56, price-to-sales of 20.49. Over the past 52 weeks the stock has ranged between $20.13 and $51.19, and currently trades 1.5% below its 52-week high.

On profitability, HTFL generates a return on equity (ROE) of -42.25%, return on capital employed of -24.23%, an operating margin of -36.13%, a net profit margin of -55.82%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides